Alvin Luk is the founder of Neurophth Therapeutics. Neurophth Therapeutics has raised $125M in total funding. Latest round: Series C+.
Alvin Luk is the founder and scientific leader of Neurophth Therapeutics, a biotech company focused on developing gene therapies for Leber hereditary optic neuropathy (LHON). He has presented clinical data on the safety and efficacy of their rAAV2-ND4 gene therapy and oversees strategic partnerships.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide